Chris Hannay
@hannay.bsky.social
📤 5177
📥 281
📝 13
Health and business reporter at The Globe and Mail
reposted by
Chris Hannay
The Globe and Mail
5 days ago
loading . . .
Public health plans should cover Mounjaro for type 2 diabetes, Canada’s Drug Agency recommends
Non-binding recommendation comes with stipulation that Eli Lilly offer the drug at a discount
https://www.theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/?utm_source=dlvr.it&utm_medium=bluesky
1
5
1
reposted by
Chris Hannay
The Globe and Mail
8 days ago
loading . . .
Apotex wins tentative FDA approval for generic Ozempic, drug makers await Health Canada decisions
U.S. market will not open till patent expires in 2032, but individual generics can be sold in Canada once approved
https://www.theglobeandmail.com/business/economy/article-apotex-fda-approval-generic-ozempic-drug-health-canada-decisions/?utm_source=dlvr.it&utm_medium=bluesky
0
13
3
reposted by
Chris Hannay
André Picard @picardonhealth
11 days ago
Government probes into deaths of two plasma donors find no link to Grifols’ donation process. Advocates call for inquiry into company's operations, by
@temurdur.bsky.social
@hannay.bsky.social
www.theglobeandmail.com/canada/artic...
via
@theglobeandmail.com
loading . . .
Government probes into deaths of two plasma donors find no link to Grifols’ donation process
Advocate calls for formal inquiry into company’s operations, citing concerns over Health Canada’s investigation of the deaths
https://www.theglobeandmail.com/canada/article-government-probes-into-deaths-of-two-plasma-donors-find-no-link-to/
1
5
3
reposted by
Chris Hannay
The Globe and Mail
18 days ago
loading . . .
Ottawa, drug companies launch task force to prepare for USMCA talks
Group plans to meet every two weeks and prepare a report in 90 days with options for Canada’s response
https://www.theglobeandmail.com/business/economy/article-ottawa-drug-companies-launch-task-force-to-prepare-for-usmca-talks/?utm_source=dlvr.it&utm_medium=bluesky
0
3
4
reposted by
Chris Hannay
The Globe and Mail
19 days ago
loading . . .
Health Canada imposes new conditions on Grifols after deaths of two people who donated plasma
Regulator says Grifols centres must reduce number of appointments, better supervise new staff and improve donor records
https://www.theglobeandmail.com/canada/article-grifols-health-canada-terms-conditions-blood-plasma/?utm_source=dlvr.it&utm_medium=bluesky
1
4
1
reposted by
Chris Hannay
The Globe and Mail
25 days ago
loading . . .
Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
VP tells House of Commons committee that donors are informed of risk of death during the procedure
https://www.theglobeandmail.com/canada/article-grifols-donors-plasma-drugs-sold-overseas-mps-hear/?utm_source=dlvr.it&utm_medium=bluesky
0
9
5
reposted by
Chris Hannay
The Globe and Mail
27 days ago
loading . . .
Why Canada spends $1-billion a year on drugs made from blood plasma
Demand growing for immunoglobulin to address immune deficiencies that can result from cancer treatment
https://www.theglobeandmail.com/business/economy/article-canadian-blood-services-budget-plasma/?utm_source=dlvr.it&utm_medium=bluesky
0
10
4
reposted by
Chris Hannay
The Globe and Mail
28 days ago
loading . . .
Generic Ozempic makes debut in India, ahead of Canada where it became legal months ago
Generic versions of diabetes and weight-loss drug became legal in early January
https://www.theglobeandmail.com/business/economy/article-generic-ozempic-makes-debut-in-india-ahead-of-canada-where-it-became/?utm_source=dlvr.it&utm_medium=bluesky
0
11
5
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
Ontario to create electronic medical record system to streamline patient data sharing
Centralized record-keeping system would allow GPs to more easily access health care data
https://www.theglobeandmail.com/canada/article-ontario-health-care-record-keeping-medical-system/?utm_source=dlvr.it&utm_medium=bluesky
4
5
4
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
Loved ones seek answers after 22-year-old student dies while donating plasma at for-profit site in Winnipeg
Health Canada says four such deaths have occurred in the last 10 years, as Manitoba mulls a ban on the practice
https://www.theglobeandmail.com/canada/article-loved-ones-seek-answers-after-22-year-old-student-dies-while-donating/?utm_source=dlvr.it&utm_medium=bluesky
0
7
4
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
Health Canada reviewing deaths of two people who donated plasma at private centres in Winnipeg
Grifols, which runs the centres, says it’s co-operating with the government and doing its own investigation
https://www.theglobeandmail.com/business/economy/article-health-canada-grifols-plasma-winnipeg/?utm_source=dlvr.it&utm_medium=bluesky
0
9
8
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
Ottawa should prioritize reviews and procurement of Canadian-made drugs, manufacturers say
Actions of Trump administration, other jurisdictions driving major shift in how drugs are made, Apotex CEO says
https://www.theglobeandmail.com/business/economy/article-ottawa-should-prioritize-reviews-and-procurement-of-canadian-made/?utm_source=dlvr.it&utm_medium=bluesky
1
10
2
reposted by
Chris Hannay
The Globe and Mail
about 1 month ago
loading . . .
U.S. FDA says it met with states interested in importing cheaper drugs from Canada
Program has been met with disapproval from Ottawa
https://www.theglobeandmail.com/business/economy/article-us-fda-says-it-met-with-states-interested-in-importing-cheaper-drugs/?utm_source=dlvr.it&utm_medium=bluesky
6
13
9
reposted by
Chris Hannay
The Globe and Mail
about 2 months ago
loading . . .
What will change in Canada when generic Ozempic hits the market, according to our reporters
Readers asked about GLP-1 side effects, weight loss while on Ozempic and insurance coverage
https://www.theglobeandmail.com/life/article-ozempic-wegovy-mounjaro-side-effects-weight-loss-glp-1/?utm_source=dlvr.it&utm_medium=bluesky
1
9
3
reposted by
Chris Hannay
André Picard @picardonhealth
about 2 months ago
Skinny, Inc. Part 2: The big business of Ozempic. How generic semaglutide will mean lower prices and more options, w/
@hannay.bsky.social
,
@kellygrant1.bsky.social
, Kasia Mychajlowycz
www.theglobeandmail.com/podcasts/the...
www.theglobeandmail.com/business/eco...
via
@theglobeandmail.com
loading . . .
Canada will be a launching pad in the global race for generic Ozempic
Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up in the rapidly growing weight-loss market
https://www.theglobeandmail.com/business/economy/article-generic-ozempic-canada-drugmakers/
0
8
1
reposted by
Chris Hannay
The Globe and Mail
about 2 months ago
loading . . .
Ottawa says provinces should pay for nurse practitioners, gives one-year grace before penalties
New policy amounts to one of the most significant updates of the Canada Health Act in years
https://www.theglobeandmail.com/business/economy/article-ottawa-says-provinces-should-pay-for-nurse-practitioners-gives-one/?utm_source=dlvr.it&utm_medium=bluesky
4
15
8
reposted by
Chris Hannay
Susan Krashinsky Robertson
2 months ago
Online pharmacy services have boomed, and advertisements for quick access to in-demand drugs are all over social media. But many of these promotions are violating Canadian regulations on prescription-drug advertising, a Globe and Mail analysis has found.
www.theglobeandmail.com/canada/artic...
loading . . .
Dozens of online-pharmacy ads, including for weight-loss drugs, appear to violate federal rules
By making certain promises to customers, some companies are running afoul of Canadian drug advertising laws
https://www.theglobeandmail.com/canada/article-skinny-inc-online-pharmacy-ads-weight-loss-drugs-federal-rules/
0
1
1
reposted by
Chris Hannay
The Globe and Mail
2 months ago
loading . . .
Dozens of online-pharmacy ads, including for weight-loss drugs, appear to violate federal rules
By making certain promises to customers, some companies are running afoul of Canadian drug advertising laws
https://www.theglobeandmail.com/canada/article-skinny-inc-online-pharmacy-ads-weight-loss-drugs-federal-rules/?utm_source=dlvr.it&utm_medium=bluesky
2
16
11
reposted by
Chris Hannay
The Globe and Mail
2 months ago
loading . . .
Ottawa says digital prescription tool cancelled because it failed to replace fax machines
Low adoption and the lack of a cost-sharing model ultimately ended the program
https://www.theglobeandmail.com/business/economy/article-digital-prescription-tool-cancelled-failed-to-replace-fax-machines/?utm_source=dlvr.it&utm_medium=bluesky
3
6
6
reposted by
Chris Hannay
The Globe and Mail
2 months ago
loading . . .
Federal ‘axe the fax’ e-prescribing service built with Telus Health to shutter after $250-million spent
Launched in 2017, PrescribeIT is live in eight provinces and territories, but usage has remained low despite thousands of pharmacies signing on
https://www.theglobeandmail.com/business/economy/article-federal-axe-the-fax-e-prescribing-service-built-with-telus-health-to/?utm_source=dlvr.it&utm_medium=bluesky
4
7
6
reposted by
Chris Hannay
André Picard @picardonhealth
2 months ago
PrescribeIT, a federal ‘axe the fax’ e-prescribing service built with Telus Health, to shutter after $250-million spent, by
@hannay.bsky.social
@kellygrant1.bsky.social
www.theglobeandmail.com/business/eco...
via
@theglobeandmail.com
loading . . .
Federal ‘axe the fax’ e-prescribing service built with Telus Health to shutter after $250-million spent
Launched in 2017, PrescribeIT is live in eight provinces and territories, but usage has remained low despite thousands of pharmacies signing on
https://www.theglobeandmail.com/business/economy/article-federal-axe-the-fax-e-prescribing-service-built-with-telus-health-to/
7
17
9
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Drug makers say they are not working with Florida on plan to import Canadian drugs
Florida Governor Ron DeSantis had proposed importing medication from Canada to address high prices
https://www.theglobeandmail.com/business/economy/article-drug-makers-florida-import-drugs-canada-ron-desantis/?utm_source=dlvr.it&utm_medium=bluesky
3
10
12
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Ontario’s optometrists urge province to expand services they can provide
Ontario Medical Association opposes proposal though optometrists can perform the procedures elsewhere in Canada
https://www.theglobeandmail.com/business/economy/article-ontario-optometrist-procedures-health-care-expand-practice/?utm_source=dlvr.it&utm_medium=bluesky
1
4
2
Sales of GLP-1 drugs have exploded in Canada. We may just be getting started. Sales of Ozempic, Wegovy and Mounjaro totaled nearly $4b in 2025. Generics come out this year. I explore it all in a new feature that launches a series we're calling Skinny Inc:
www.theglobeandmail.com/business/eco...
3 months ago
0
0
1
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
How Canada will be a launching pad for the global race for generic Ozempic
Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up in the rapidly growing weight-loss market
https://www.theglobeandmail.com/business/economy/article-generic-ozempic-canada-drugmakers/?utm_source=dlvr.it&utm_medium=bluesky
0
5
5
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Doctors look to AI to cut burdensome administrative work
In a CMA survey, more than nine in 10 doctors said extra paperwork was harming their professional fulfilment and contributing to burnout
https://www.theglobeandmail.com/business/economy/article-ai-artificial-intelligence-doctors-physicians-hospitals/?utm_source=dlvr.it&utm_medium=bluesky
0
2
1
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Ontario pharmacy regulator sides with teachers insurance plan over prescription exclusivity complaint
Ruling goes against the regulator’s own zero-tolerance policy on such deals, advocates say
https://www.theglobeandmail.com/business/article-ontario-pharmacy-regulator-teacher-complaint-drug/?utm_source=dlvr.it&utm_medium=bluesky
0
3
2
Some good reminders here, including: stop doomscrolling!
add a skeleton here at some point
3 months ago
0
1
0
reposted by
Chris Hannay
André Picard @picardonhealth
3 months ago
Health Canada considering using decisions of foreign regulators for some drug approvals. Including U.S. FDA on forthcoming list has not been ruled out, by
@kellygrant1.bsky.social
@hannay.bsky.social
www.theglobeandmail.com/canada/artic...
via
@theglobeandmail.com
loading . . .
Health Canada considering using decisions of foreign regulators for some drug approvals
Neither Health Minister’s office nor federal regulator ruled out including U.S. FDA on forthcoming list
https://www.theglobeandmail.com/canada/article-health-canada-foreign-regulators-drug-approvals/
9
32
28
reposted by
Chris Hannay
The Globe and Mail
3 months ago
loading . . .
Health Canada considering using decisions of foreign regulators for some drug approvals
Neither Health Minister’s office nor federal regulator ruled out including U.S. FDA on forthcoming list
https://www.theglobeandmail.com/canada/article-health-canada-foreign-regulators-drug-approvals/?utm_source=dlvr.it&utm_medium=bluesky
1
11
4
On the first day generic Ozempic/Wegovy became legal, none of the many generic drug submissions were approved. Novo Nordisk is ready, though, and has just received Health Canada approval for a product it says will challenge its generic competitors.
www.theglobeandmail.com/canada/artic...
loading . . .
Novo Nordisk prepares new cheaper version of Ozempic as generics face delays
Health Canada has yet to approve generics despite applications made as far back as 2024
https://www.theglobeandmail.com/canada/article-ozempic-cheaper-version-novo-nordisk-health-canada-generics/
4 months ago
0
9
1
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
Novo Nordisk prepares new cheaper version of Ozempic as generics face delays
Health Canada has yet to approve generics despite applications made as far back as 2024
https://www.theglobeandmail.com/canada/article-ozempic-cheaper-version-novo-nordisk-health-canada-generics/?utm_source=dlvr.it&utm_medium=bluesky
0
14
3
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
How an Ontario chronic pain clinic is taking a new approach for long-lasting relief
Excessive pain treatments harm patients and cost the province millions of dollars per year. Physician Zameer Pirani believes he has a better way
https://www.theglobeandmail.com/business/economy/article-clinic-chronic-pain-treatments-health-care-long-lasting/?utm_source=dlvr.it&utm_medium=bluesky
1
8
6
Eli Lilly is making significant cuts to the cost of Mounjaro and Zepbound in Canada. Lilly hasn't made inroads in Canada the way it has in the U.S., but between this and generic Ozempic, 2026 could be a big year for GLP-1s
www.theglobeandmail.com/business/art...
loading . . .
Eli Lilly & Co. cuts price of popular diabetes and weight-loss drugs in Canada
The move comes ahead of new regulations and the expected arrival of cheaper generic Ozempic
https://www.theglobeandmail.com/business/article-eli-lilly-co-cuts-price-of-popular-diabetes-and-weight-loss-drugs-in/
4 months ago
0
5
1
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
Eli Lilly & Co. cuts price of popular diabetes and weight-loss drugs in Canada
The move comes ahead of new regulations and the expected arrival of cheaper generic Ozempic
https://www.theglobeandmail.com/business/article-eli-lilly-co-cuts-price-of-popular-diabetes-and-weight-loss-drugs-in/?utm_source=dlvr.it&utm_medium=bluesky
2
30
11
reposted by
Chris Hannay
The Globe and Mail
4 months ago
loading . . .
Competition Bureau obtains court order for Well Health investigation
Investigation began after a series of acquisitions involving Well Health and Healwell AI
https://www.theglobeandmail.com/business/economy/article-well-health-competition-bureau-investigation-healwell-ai-health-care/?utm_source=dlvr.it&utm_medium=bluesky
0
2
1
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
Hims & Hers acquires Livewell in Canada in anticipation of generic Ozempic
One of largest U.S. telehealth providers expects to ride wave of exploding demand for weight-loss drug semaglutide when it becomes available
https://www.theglobeandmail.com/business/economy/article-hims-hers-launches-in-canada-in-anticipation-of-generic-ozempic/?utm_source=dlvr.it&utm_medium=bluesky
0
3
3
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
New pet pharmacies could help owners manage rising costs as access opens up
Market for pet medication widens after national distributor, drug makers allow pharmacies to order
https://www.theglobeandmail.com/business/economy/article-pet-pharmacies-veterinary-prescriptions-medications/?utm_source=dlvr.it&utm_medium=bluesky
0
4
3
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
Canada’s public drug plans, Novo Nordisk end talks to cover Wegovy
Drug prescribed for weight loss contains same active ingredient as Ozempic, which is prescribed for patients with type 2 diabetes
https://www.theglobeandmail.com/business/economy/article-canadas-public-drug-plans-novo-nordisk-end-talks-to-cover-wegovy/?utm_source=dlvr.it&utm_medium=bluesky
0
3
2
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
Alberta’s move to open private billing unlikely to increase capacity, physicians say
Experts concerned that few physicians will be enticed by Alberta’s ‘dual practice’ surgery model
https://www.theglobeandmail.com/business/economy/article-alberta-health-care-private-billing-physicians/?utm_source=dlvr.it&utm_medium=bluesky
1
14
7
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
Medical software provider Well Health under investigation by Competition Bureau
Bureau says company’s vertical integration of businesses could make it hard for other companies to compete
https://www.theglobeandmail.com/business/article-well-health-technologies-investigation-competition-bureau-health-care/?utm_source=dlvr.it&utm_medium=bluesky
0
6
1
reposted by
Chris Hannay
Judith Pereira
5 months ago
When
@hannay.bsky.social
first mentioned that there was a different illustration in the Love Your Forever that he had read as a child and the one he read to his children, I was intrigued. Here's what he found out.
#robertmunsch
#reading
#booksky
www.theglobeandmail.com/culture/book...
loading . . .
An illustration in Robert Munsch’s beloved Love You Forever didn’t seem right. I set out to discover why
I memorized every word of Love You Forever as a kid, but when I read it to my own children, one page left me unsettled
https://www.theglobeandmail.com/culture/books/article-robert-munsch-love-you-forever-illustration-mystery/
0
9
7
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
Haunted by an illustration in Munsch’s beloved Love You Forever that just didn’t seem right, I set out to find out why
I memorized every word of Love You Forever as a kid, but when I read it to my own children, one page left me unsettled
https://www.theglobeandmail.com/culture/books/article-robert-munsch-love-you-forever-illustration-mystery/?utm_source=dlvr.it&utm_medium=bluesky
0
4
2
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
The bureaucracy slowing down access to life-saving pharmacare
Canadians can often wait years to get access to drugs that regulators have already deemed to be safe
https://www.theglobeandmail.com/podcasts/the-decibel/article-bureaucracy-slowing-down-access-life-saving-pharmacare-health-canada/?utm_source=dlvr.it&utm_medium=bluesky
0
1
1
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
Health Canada approval backlog expected to push back arrival of generic Ozempic
Drugmakers say approvals for generics likely won’t be ready when Ozempic’s market exclusivity ends in January
https://www.theglobeandmail.com/business/economy/article-health-canada-approval-backlog-expected-to-push-back-arrival-of/?utm_source=dlvr.it&utm_medium=bluesky
0
8
1
A group of hospital physicians met for a virtual rounds meeting. What they didn't realize was that
Otter.ai
was on the call, too. They found out when the AI transcriber sent a transcript of the meeting -- patient information and all -- to dozens of current and former staff after the call.
loading . . .
AI bot recorded doctors’ meeting, sent patient info to current and former hospital staff, watchdog says
The transcription tool recorded the meeting on behalf of a physician who no longer worked at the hospital
https://www.theglobeandmail.com/canada/article-ai-bot-doctors-meeting-patient-info-hospital-privacy-watchdog/
5 months ago
0
19
26
reposted by
Chris Hannay
The Globe and Mail
5 months ago
loading . . .
U.S. pushes drugmakers to reveal confidential details of contracts with Canada, other countries
Washington turning up pressure on manufacturers to lower U.S. drug prices and raise them elsewhere
https://www.theglobeandmail.com/business/economy/article-us-pushes-drugmakers-reveal-contracts-with-canada-other-countries/?utm_source=dlvr.it&utm_medium=bluesky
3
8
7
reposted by
Chris Hannay
The Globe and Mail
6 months ago
loading . . .
Ontario to ban exclusivity deals between insurers, pharmacies
Move follows Globe reporting on closed preferred pharmacy networks that restrict where patients can buy medication
https://www.theglobeandmail.com/business/economy/article-ontario-ban-drug-insurance-pharmacy-exclusivity-deals-ppns-closed/?utm_source=dlvr.it&utm_medium=bluesky
1
16
8
reposted by
Chris Hannay
André Picard @picardonhealth
6 months ago
Myeloma patients demand immunotherapy pricing talks resume. Carvykti was approved by Health Canada in 2023, but still unavailable to cancer patients due to lack of deal on price, by
@kellygrant1.bsky.social
@hannay.bsky.social
www.theglobeandmail.com/canada/artic...
via
@theglobeandmail.com
loading . . .
Myeloma patients launch campaign for immunotherapy pricing talks to resume
Health Canada approved cutting-edge treatment nearly three years ago but it still isn’t available here
https://www.theglobeandmail.com/canada/article-cancer-medication-carvykti-health-canada-approval-advocacy-myeloma/
0
11
8
reposted by
Chris Hannay
The Globe and Mail
6 months ago
loading . . .
Canadians can wait years to get drugs regulators have already deemed safe. Why?
Even after treatments pass Health Canada’s review, getting them publicly reimbursed here takes longer than any other G7 country
https://www.theglobeandmail.com/canada/article-canadians-can-wait-years-to-get-drugs-regulators-have-already-deemed/?utm_source=dlvr.it&utm_medium=bluesky
0
9
9
Load more
feeds!
log in
